CEVEC Pharmaceuticals GmbH
Records under this name other than the patents CEVEC Pharmaceuticals GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Showing 1 to 3 of 3 · Back to CEVEC Pharmaceuticals GmbH
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,315,773 | Method for the production of permanent human cell lines Term ended Ended no later than Mar 7, 2026 · From the USPTO record | Term ended | Ended no later than Mar 7, 2026 | From the USPTO record |
| US 6,558,948 | Permanent amniocytic cell line, its production and use for the production of gene transfer vectors Term ended Term ended Nov 16, 2020 · From the USPTO record | Term ended | Term ended Nov 16, 2020 | From the USPTO record |
| US 7,488,749 | Therapy of diseases of the eye, the inner ear and the central nervous system Lapsed on the fee record Ended Feb 10, 2013 · From the USPTO record | Lapsed on the fee record | Ended Feb 10, 2013 | From the USPTO record |